SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-002214
Filing Date
2019-02-12
Accepted
2019-02-12 15:07:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13G sc13g1218a3nineteen_protalix.htm SC 13G/A 27001
  Complete submission text file 0001213900-19-002214.txt   28838
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 19590200
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1 NORTH WACKER CHICAGO IL 60606
Business Address 1 NORTH WACKER CHICAGO IL 60606 312-525-6064
Nineteen77 Global Multi-Strategy Alpha Master Ltd (Filed by) CIK: 0001698095 (see all company filings)

IRS No.: 980227879 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A